Clinical and genotypic CMV drug resistance in HSCT recipients: a single center epidemiological and clinical data

Bone Marrow Transplant. 2019 Jan;54(1):146-149. doi: 10.1038/s41409-018-0257-7. Epub 2018 Jun 27.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Aged
  • Allografts
  • Cytomegalovirus / genetics*
  • Cytomegalovirus Infections* / drug therapy
  • Cytomegalovirus Infections* / genetics
  • Cytomegalovirus Infections* / mortality
  • DNA, Viral / genetics
  • Drug Resistance, Viral / genetics*
  • Female
  • Follow-Up Studies
  • Hematologic Diseases* / genetics
  • Hematologic Diseases* / mortality
  • Hematologic Diseases* / therapy
  • Hematologic Diseases* / virology
  • Hematopoietic Stem Cell Transplantation*
  • Humans
  • Male
  • Middle Aged
  • Prospective Studies
  • Transplantation Conditioning*
  • Valganciclovir / administration & dosage*

Substances

  • DNA, Viral
  • Valganciclovir